Phase II study of protracted irinotecan infusion and a low-dose cisplatin for metastatic gastric cancer

doi:10.3748/wjg.v12.i40.6522

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 40

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2218)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

290

HTML

1686

Figures (1-1)

123

Tables (1-3)

119

Sum=2218

Oct 28, 2006 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Oct 28, 2006; 12(40): 6522-6526
Published online Oct 28, 2006. doi: 10.3748/wjg.v12.i40.6522

Open in New Tab Full Size Figure Download Figure

Figure 1 Survival curves of all patients and patients without prior chemotherapy. ━: Survival curve of all patients (median survival time, 378 d). …: Survival curve of patients without priorchemotherapy (median survival time, 509 d).

Citation: Imamura H, Ikeda M, Furukawa H, Tsujinaka T, Fujitani K, Kobayashi K, Narahara H, Kato M, Imamoto H, Takabayashi A, Tsukuma H. Phase II study of protracted irinotecan infusion and a low-dose cisplatin for metastatic gastric cancer. World J Gastroenterol 2006; 12(40): 6522-6526
URL: https://www.wjgnet.com/1007-9327/full/v12/i40/6522.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i40.6522